Form D · Biotechnology
Diagnostic Biochips, Inc.
Glen Burnie, MD · CIK 0001592600
Offering snapshot reported Mar 3, 2021 · SEC filing
- Reported sold
- $1.08M Offering amount: $1.5M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 17, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2021 | Initial | $1,084,649 | No comparison | 17 | SEC filing |
| Oct 18, 2017 | Initial | $75,000 | No comparison | 1 | SEC filing |
| Nov 25, 2013 | Initial | $150,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-391103
The total amount sold reflects approximately $154,650 in converted securities and the remainder in cash consideration.
Source: Form D, filed Mar 3, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Greg Alden | Director, Executive |
| Walter W. Buckley, Iii | Director |
| Robert Seaton Collins | Director |
| Brian Glenn Jamieson | Director, Executive |
| Robert E. Keith, Jr. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
802 Cromwell Park Drive Suites L P
Glen Burnie, MD, 21061
Glen Burnie, MD, 21061